EP2863890A4 - fenofibrate - Google Patents

fenofibrate

Info

Publication number
EP2863890A4
EP2863890A4 EP12880074.5A EP12880074A EP2863890A4 EP 2863890 A4 EP2863890 A4 EP 2863890A4 EP 12880074 A EP12880074 A EP 12880074A EP 2863890 A4 EP2863890 A4 EP 2863890A4
Authority
EP
European Patent Office
Prior art keywords
fenofibrate
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP12880074.5A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2863890A1 (en
Inventor
Sarat C Chattaraj
Glenn Allen Redelman
Andrew Alan Shaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Inc
Original Assignee
Mylan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Inc filed Critical Mylan Inc
Publication of EP2863890A1 publication Critical patent/EP2863890A1/en
Publication of EP2863890A4 publication Critical patent/EP2863890A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP12880074.5A 2012-06-25 2012-06-25 fenofibrate Pending EP2863890A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/043971 WO2014003706A1 (en) 2012-06-25 2012-06-25 Fenofibrate formulation

Publications (2)

Publication Number Publication Date
EP2863890A1 EP2863890A1 (en) 2015-04-29
EP2863890A4 true EP2863890A4 (en) 2015-12-09

Family

ID=49783663

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12880074.5A Pending EP2863890A4 (en) 2012-06-25 2012-06-25 fenofibrate

Country Status (5)

Country Link
EP (1) EP2863890A4 (enrdf_load_stackoverflow)
BR (1) BR112014032579A2 (enrdf_load_stackoverflow)
CA (1) CA2877901A1 (enrdf_load_stackoverflow)
IN (1) IN2014DN11044A (enrdf_load_stackoverflow)
WO (1) WO2014003706A1 (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101925590B1 (ko) * 2016-08-30 2018-12-05 대원제약 주식회사 개선된 생체이용률을 갖는 페노피브릭산 제제

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040137055A1 (en) * 1999-07-09 2004-07-15 Bruno Criere Pharmaceutical composition containing fenofibrate and method for the preparation thereof
WO2008014175A2 (en) * 2006-07-28 2008-01-31 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
US20100166857A1 (en) * 2008-12-30 2010-07-01 Dong Yan Pharmaceutical dosage forms and methods of manufacturing same
US20110217369A1 (en) * 2009-09-03 2011-09-08 Ranbaxy Laboratories Limited Fenofibrate compositions
US20110311619A1 (en) * 2008-12-24 2011-12-22 Ethypharm Pharmaceutical formulation of nanonised fenofibrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US20080241070A1 (en) * 2000-09-21 2008-10-02 Elan Pharma International Ltd. Fenofibrate dosage forms
AU2006212609A1 (en) * 2005-02-10 2006-08-17 Lifecycle Pharma A/S A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an HMG-CoA reductase inhibitor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040137055A1 (en) * 1999-07-09 2004-07-15 Bruno Criere Pharmaceutical composition containing fenofibrate and method for the preparation thereof
WO2008014175A2 (en) * 2006-07-28 2008-01-31 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
US20110311619A1 (en) * 2008-12-24 2011-12-22 Ethypharm Pharmaceutical formulation of nanonised fenofibrate
US20100166857A1 (en) * 2008-12-30 2010-07-01 Dong Yan Pharmaceutical dosage forms and methods of manufacturing same
US20110217369A1 (en) * 2009-09-03 2011-09-08 Ranbaxy Laboratories Limited Fenofibrate compositions

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Solubility, Delivery and ADME Problems of Drugs and Drug Candidates", 20 September 2011, article BALAZS OTTILIA: "Preclinical Formulation in Early Drug Research", pages: 77 - 77, XP055947464 *
KETAN T. SAVJANI ET AL: "Drug Solubility: Importance and Enhancement Techniques", INTERNATIONAL SCHOLARLY RESEARCH NETWORK ISRN PHARMACEUTICS, vol. 67, no. 8, 1 January 2012 (2012-01-01), pages 1 - 10, XP055328944, DOI: 10.5402/2012/195727 *
See also references of WO2014003706A1 *

Also Published As

Publication number Publication date
IN2014DN11044A (enrdf_load_stackoverflow) 2015-09-25
EP2863890A1 (en) 2015-04-29
WO2014003706A1 (en) 2014-01-03
BR112014032579A2 (pt) 2017-06-27
CA2877901A1 (en) 2014-01-03

Similar Documents

Publication Publication Date Title
CO7061086A2 (es) Combinaciones de compuestos activos
PT3725778T (pt) Formulações de enzalutamida
EP2916905A4 (en) MEDICAL CONNECTOR
EP2842540A4 (en) MEDICAL CONNECTOR
FR2997014B1 (fr) Composition sterile dermo-injectable
EP2935546A4 (en) BIORAFFINATION OF RAW TALL OIL
EP2875051A4 (en) ANTIBODIES AGAINST SIGLEC-15
AR092198A1 (es) Derivados de pirazolopirimidinas
BR112014013850A2 (pt) conjunto de prateleiras
EP2925325A4 (en) STABILIZED FORMULATION OF PEMETREXED
EP2735260A4 (en) Endoscope
BR112014000015A2 (pt) formulação
EP2925338A4 (en) LYOPHILIZED FORMULATION OF TAT-NR2B9C
PT2825039T (pt) Formulação de ibuprofeno injetável
EP2821053A4 (en) CLEANSING COMPOSITION FOR THE SKIN
EP2799000A4 (en) Borescope
BR112014026553A2 (pt) Fralda descartável
PL2812013T3 (pl) Formulacja do leczenia ibs
EP2858975A4 (en) FBXO3 INHIBITORS
HRP20182057T1 (hr) Temperaturno stabilni vodeni pripravci klokintocet-meksila
EP2931176A4 (en) Medical sling
PT2908835T (pt) Formulações estáveis
EP2851085A4 (en) STERILIZED COMPOSITION
EP2770828A4 (en) FORMULATION
FR2987600B1 (fr) Nacelle aplatie de turboreacteur

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150126

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20151111

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/50 20060101ALI20151105BHEP

Ipc: A61K 9/48 20060101ALI20151105BHEP

Ipc: A61K 9/16 20060101ALI20151105BHEP

Ipc: A61K 9/14 20060101AFI20151105BHEP

Ipc: A61P 3/06 20060101ALI20151105BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

R17P Request for examination filed (corrected)

Effective date: 20150126

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180131

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0009140000

Ipc: A61K0009160000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/06 20060101ALI20240403BHEP

Ipc: A61K 9/50 20060101ALI20240403BHEP

Ipc: A61K 9/48 20060101ALI20240403BHEP

Ipc: A61K 9/16 20060101AFI20240403BHEP

INTG Intention to grant announced

Effective date: 20240425

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

INTC Intention to grant announced (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20250206

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN